CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
to be used in future studies in study participants diagnosed with acute myeloid leukemia (AML), myelodysplastic s...
Phase 1, Phase 2
Miami, Florida, United States and 33 other locations
People with acute myeloid leukemia (AML) are usually treated with chemotherapy. Some people with AML hav...
Phase 1, Phase 2
Pembroke Pines, Florida, United States and 19 other locations
Anti-tumor Activity of LYT- 200 in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML), or with Relaps...
Phase 1
Miami, Florida, United States and 10 other locations
study of five dose levels of APVO436 in combination with venetoclax and azacitidine (ven/aza) in adult patients with newly diagnosed, CD123+ AML...
Phase 1
Miami, Florida, United States and 6 other locations
subjects with previously treated or untreated with high risk factor acute myeloid leukemia (AML). Venetoclax and ...
Phase 1
Miami, Florida, United States and 3 other locations
in combination with venetoclax for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults who ar...
Phase 1, Phase 2
Plantation, Florida, United States and 33 other locations
). Both parts will be conducted in participants with previously untreated CD123+ AML who are ineligible for intensive chemotherapy....
Phase 2
Miami, Florida, United States and 32 other locations
VEN+AZA alone for the treatment of participants with newly diagnosed Acute Myeloid Leukemia (AML) with a mutation...
Phase 3
Weston, Florida, United States and 180 other locations
participants with AML.The duration of this multi-phase study is approximately 7 years....
Phase 2, Phase 3
Miami, Florida, United States and 71 other locations
engineered T-cells (CD4CAR) in patients with relapsed or refractory AML. The study will evaluate safety in this patient population and also ...
Phase 1
Miami, Florida, United States and 3 other locations
Clinical trials
Research sites
Resources
Legal